It is beyond the scope of this article to describe all possible drug-drug interactions in persons taking HIV antiretroviral medications, but this section will identify the most frequent interactions ...
In a single-center audit, 27% of patients receiving antiretrovirals were at risk for having a clinically significant drug interaction, but treating physicians identified only 36% of these potential ...
Please provide your email address to receive an email when new articles are posted on . HIV PrEP agents, including long-acting cabotegravir, had no effect on hormonal contraceptives. ViiV Healthcare ...
Dovato (dolutegravir/lamivudine) is a prescription tablet that’s used to treat HIV. It has interactions with certain prescription and over-the-counter medications ...
This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Today we're going ...
An HIV-derived nucleoside therapy now treats rare genetic diseases by restoring mitochondrial DNA and improving muscle ...
HIV-1 protease is a critical enzyme in the viral life cycle, facilitating the maturation of infectious viral particles by cleaving precursor polyproteins. The emergence of drug resistance, driven by ...
Conclusion Obviously, no clinician can memorize every possible drug interaction. Having worked with HIV patients and medications every day for years, I still find it difficult to keep up with the ever ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results